作者: Randy Lee Webb , David Saul Cohen , Marc De Gasparo
DOI:
关键词: Valsartan 、 Benazeprilat 、 Benazepril 、 Medicine 、 Pharmacology 、 Heart failure
摘要: The invention relates to pharmaceutical combination compositions for the treatment of hypertension, congestive heart failure and renal failure, comprising (1) ACE-inhibitor benazepril formula (I) or benazeprilat (II) a pharmaceutically acceptable salt thereof, (2) AT1-antagonist valsartan (III) as weel methods failure.